ingredientErlotinib 150mg
substitutesErlonat 150 mg, Tarceva 150mg 10s x 3
Shipping classRoom Temperature
Medicine Overview by Anukar Pharmacy
( Erlocip 150mg 30s Tablet )
TreatmentErlocip 150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Side EffectsNausea, Vomiting, Fatigue, Breathing difficulty, Abdominal pain, Edema (swelling), Weight loss,Loss of appetite, Anemia (low number of red blood cells), Infection, Bone pain, Constipation, Diarrhoea, Fever, Stomatitis (Inflammation of the mouth), Rash
Method of UseTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlocip 150mg Tablet is to be taken empty stomach.
How WorksErlocip 150mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
More Info by Anukar Pharmacy
( Erlocip 150mg 30s Tablet )
Suggestions
- Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food.
- Erlotinib is not recommended for children and adolescents under 18 years of age.
- Stop smoking and use effective contraceptive measures while on erlotinib treatment.
- Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilbert??s syndrome (liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or breast-feeding.
- Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light, increased eye watering.
Warning by Anukar Pharmacy
( Erlocip 150mg 30s Tablet )
Special precautions for ( Erlocip 150mg 30s Tablet ) Heads up
| aspect | highlight | details |
|---|---|---|
Alcohol
|
Interaction with alcohol is unknown. Please consult your doctor. | |
Pregnancy
|
WEIGH RISKS VS BENEFITS | Erlocip 150mg Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor. |
Lactation
|
caution | Erlocip 150mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby. |
Driving
|
It is not known whether Erlocip 150mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. | |
Kidney
|
safe | Erlocip 150mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Erlocip 150mg Tablet is recommended. Use of this medicine is not advised in patients with severe kidney disease. |
Liver
|
caution | Erlocip 150mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Erlocip 150mg Tablet may be needed. Please consult your doctor. Limited information is available on the use of Erlocip 150mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease. |
Suggestion by Anukar Pharmacy on missing a dose
( Erlocip 150mg 30s Tablet )
If you miss a dose of Erlocip 150mg Tablet, skip it and continue with your normal schedule. Do not double the dose.
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.
| 药名 | 特罗凯, 厄洛替尼 |
| 厂家 | Cipla |
| 成分 | Erlotinib |
| 说明 |
特罗凯（erlotinib）是一种抗癌药物，可干扰癌细胞的生长并减缓其在体内的扩散。Erlocip用于治疗已扩散到身体其他部位（转移性）的非小细胞肺癌或胰腺癌。
肺癌、胰腺癌
|
* 以上中文信息由印度阿努卡药房收集的Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）中文网络信息和软件翻译获得，阿努卡药房认为Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）中文产品介绍信息存在与Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）实际数据不一致的可能。阿努卡药房请用户把Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）页面数据作为参考。印度阿努卡药房建议用户在实际使用Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）数据或者信息时，以Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）制造商公开发布的Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）商品信息为参考。使用方法，以用户医生建议使用Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）决定为参考。用户任何关于Erlocip 150mg 30s Tablet, Cipla（特罗凯, 厄洛替尼）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
